Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain

NCT00452777 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

193

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathic Pain

Interventions

DRUG: BVT.115959
DRUG: Placebo

Sponsor

Swedish Orphan Biovitrum